Gold prices tick higher on fresh US tariff threats, Fed rate cut hopes
LifeMD , Inc. (NASDAQ:LFMD) Chairman and CEO Justin Schreiber sold 25,000 shares of common stock on August 1, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $9.9876, for a total value of $249,690. The stock, which has surged nearly 150% year-to-date and maintains impressive gross profit margins of 88%, currently trades at $11.84. InvestingPro analysis indicates the stock is trading above its Fair Value.
The prices for the sales ranged from $9.80 to $10.23. Following the transaction, Schreiber directly owns 200,000 shares of LifeMD, Inc. common stock and indirectly owns 2,475,721 shares through Schreiber Holdings LLC, 13,997 shares By Child 1, and 13,997 shares By Child 2. With a market capitalization of $540 million, these insider transactions are closely monitored by investors. Discover more insider trading patterns and 12 additional InvestingPro Tips for LFMD.
In other recent news, LifeMD, Inc. reported its second-quarter financial results, which did not meet analyst expectations. The company experienced a loss of $0.06 per share, which was greater than the anticipated loss of $0.02 per share. Additionally, LifeMD’s revenue reached $62.2 million, falling short of the consensus estimate of $66.29 million, although it still represented a 23% increase compared to the previous year. The telehealth segment showed a 30% growth in revenue, reaching $48.6 million year-over-year. However, the company significantly lowered its full-year guidance due to challenges in its Rex MD business. These developments have been closely monitored by investors and analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.